0001179110-21-007339.txt : 20210702 0001179110-21-007339.hdr.sgml : 20210702 20210702170302 ACCESSION NUMBER: 0001179110-21-007339 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210702 FILED AS OF DATE: 20210702 DATE AS OF CHANGE: 20210702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pardo Geoffrey B CENTRAL INDEX KEY: 0001753143 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40545 FILM NUMBER: 211071222 MAIL ADDRESS: STREET 1: 100 DOMAIN DRIVE CITY: EXETER STATE: NH ZIP: 03833 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVRx, Inc. CENTRAL INDEX KEY: 0001235912 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 9201 WEST BROADWAY AVENUE STREET 2: SUITE 650 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 BUSINESS PHONE: 7634162850 MAIL ADDRESS: STREET 1: 9201 WEST BROADWAY AVENUE STREET 2: SUITE 650 CITY: MINNEAPOLIS STATE: MN ZIP: 55445 FORMER COMPANY: FORMER CONFORMED NAME: CVRX INC DATE OF NAME CHANGE: 20030527 4 1 edgar.xml FORM 4 - X0306 4 2021-07-02 0 0001235912 CVRx, Inc. CVRX 0001753143 Pardo Geoffrey B 9201 W BROADWAY AVE #650 MINNEAPOLIS MN 55445 1 0 0 0 Common Stock 2021-07-02 4 C 0 1554022 A 1554022 I See Footnote Common Stock 2021-07-02 4 P 0 275000 18 A 1829022 I See Footnote Series G Preferred Stock 2021-07-02 4 C 0 24583397 0 D Common Stock 1554022 0 I See Footnote Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock automatically converted into shares of common stock at a rate of 1-for-0.0632143218. These shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde IV"). The Reporting Person is a partner of Gilde IV and may be deemed to share voting and dispositive over the shares held by Gilde IV. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock. /s/ Amy C. Seidel, Attorney-in-Fact 2021-07-02